459
Participants
Start Date
August 31, 2010
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Alisporivir
ALV 200 mg soft gel capsules administered orally
Peginterferon alfa-2a
PEG 180 μg administered via subcutaneous (s.c.) injection once weekly
Ribavirin
RBV 200 mg tablets (weight-based dose: \< 75 mg = 1000 mg/day; ≥ 75 kg = 1200 mg/day) administered orally in a divided daily dose
Placebo
ALV placebo soft gel capsules administered orally
Novartis Investigative Site, Taipei
Novartis Investigative Site, Douliu
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Westmead
Novartis Investigative Site, Kogarah
Novartis Investigative Site, Kingswood
Novartis Investigative Site, Leuven
Novartis Investigative Site, Fitzroy
Novartis Investigative Site, Clayton
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Kaposvár
Novartis Investigative Site, Székesfehérvár
Novartis Investigative Site, Taipei
Novartis Investigative Site, New York
Novartis Investigative Site, Berlin
Novartis Investigative Site, Brooklyn
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Keelung
Novartis Investigative Site, Madrid
Novartis Investigative Site, Majadahonda
Novartis Investigative Site, Orlando
Novartis Investigative Site, Lin-Ko
Novartis Investigative Site, Tampa
Novartis Investigative Site, Fatih / Istanbul
Novartis Investigative Site, Bradenton
Novartis Investigative Site, Izmir
Novartis Investigative Site, Padua
Novartis Investigative Site, Bologna
Novartis Investigative Site, Seville
Novartis Investigative Site, Parma
Novartis Investigative Site, Antella - Bagno A Ripoli
Novartis Investigative Site, Cologne
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Springfield
Novartis Investigative Site, Topeka
Novartis Investigative Site, Paris
Novartis Investigative Site, Arlington
Novartis Investigative Site, Houston
Novartis Investigative Site, San Antonio
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Palermo
Novartis Investigative Site, San Diego
Novartis Investigative Site, San Diego
Novartis Investigative Site, Ventura
Novartis Investigative Site, Honolulu
Novartis Investigative Site, Honolulu
Novartis Investigative Site, Iași
Novartis Investigative Site, Springfield
Novartis Investigative Site, Egg Harbor Twp
Novartis Investigative Site, Dallas
Novartis Investigative Site, Nice
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Békéscsaba
Novartis Investigative Site, Roma
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Lódz
Novartis Investigative Site, Warsaw
Novartis Investigative Site, San Juan
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Nottingham
Lead Sponsor
Debiopharm International SA
INDUSTRY